Results per Page:
New approach aims to restore immune-powering B cells in cancer patients following successful immunotherapy with CAR T cells
New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy
Investigational immunotherapy halts advanced melanoma
Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer
Patient's cloned T cells kill tumors
Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission
For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse
The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients